Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index; 20 of the 57 sources its claims cite were checked for support.

Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Open access
Sadowski, Adam, Dunlap, Corina, Lacombe, Alison, Hanes, Douglas · 2021 · Clinical and Translational Gastroenterology

Abstract

INTRODUCTION: Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are gastrointestinal pathologies affecting large numbers of the global population and incurring significant healthcare costs. Disruptions in the gut-brain axis occurring in these conditions can lead to increased inflammation, affecting gastrointestinal and autonomic nervous system function. Heart rate variability (HRV) is commonly used to assess the state of the sympathetic and parasympathetic function of the autonomic nervous system, but it remains unclear how HRV measures are associated with gastrointestinal pathologies. Here, we conduct a systematic review of the literature comparing HRV of subjects diagnosed with IBS or IBD to HRV in healthy controls (HC). METHODS: We searched PubMed, Cochrane Library, and CINAHL (EBSCO) for eligible studies up to 2018. We included any study comparing a recognized measure of HRV between a group of patients with either IBS or IBD to a group of matched HC before any intervention. Studies were screened, and data were extracted from included articles using predefined criteria. Random effects meta-analysis was performed for each outcome, with effect size reported as the standardized mean difference. RESULTS: There were significant differences between IBD and HC in time domain HRV and significant decreases in high-frequency power measures were also noted, in both IBS and IBD compared with HC. DISCUSSION: Parasympathetic nervous system activity, represented through high-frequency power, seems to be lower in people with IBS and IBD, but conclusions are limited by the small number of studies that provide usable data, methodological heterogeneity, and high risks of bias in primary study methods and measures.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis found evidence that people with IBS or IBD have lower parasympathetic-linked HRV, especially high-frequency power, compared with healthy controls, but the authors caution that conclusions are limited by few usable studies, methodological heterogeneity, and high risk of bias. The only primary time-domain outcome with adequate data was RMSSD, which was significantly lower in IBD versus controls.

Key findings

  • Across 28 included studies, there were 2,314 participants: 956 IBS, 438 IBD, and 895 healthy controls; 18 studies (1,447 participants) provided data for meta-analysis.
  • RMSSD was significantly lower in IBD compared with healthy controls (3 studies; pooled SMD = −0.37 [−0.66, −0.07], P = 0.02, I² = 0%).
  • Absolute high-frequency HRV in short recordings was significantly lower in IBD versus controls after adult-only subanalysis (3 studies; pooled SMD = −0.51 [−0.85, −0.17], P = 0.003, I² = 16%), and HFnu was significantly lower in IBD versus controls (P = 0.0002), remaining significant for ulcerative colitis only (P = 0.001).
  • In IBS, absolute high-frequency HRV in short recordings was significantly lower than controls (4 studies; pooled SMD = −0.35 [−0.63, −0.08], P = 0.01, I² = 37%), but long recordings were not significant (3 studies; pooled SMD = −0.06 [−0.31, 0.19], P = 0.64, I² = 4%); the short-recording result remained significant in IBS-C (3 studies; pooled SMD = −0.55 [−0.86, −0.23], P = 0.0007, I² = 0%).

Methods

  • Systematic review and random-effects meta-analysis registered in PROSPERO (CRD4201800072), following PRISMA; PubMed, Cochrane Library, and CINAHL were searched through June 2018, with reference lists and trial registries also checked.
  • Eligible studies compared a recognized HRV measure between IBS or IBD patients and healthy controls before any intervention, using continuous recordings of 5 minutes to 24 hours; participants with cardiovascular disease, nervous system comorbidities, diabetes, renal failure, alcoholism, or relevant medications were excluded.
  • Pooled standardized mean differences with 95% CIs were calculated using an inverse variance model; heterogeneity was assessed with I², publication bias was investigated visually with funnel plots, and risk of bias was assessed with a modified ROBINS-I tool.

Limitations

  • The authors state the main limitations were small primary study sample sizes, significant heterogeneity in primary study methods and measures, and high risk of bias; there was also inconsistent reporting of HRV measures, recording software, timing of HRV collection, and lack of HRV assessor blinding.
  • The authors note insufficient data to compare IBS with IBD, inconsistent disease severity data, and insufficient data to draw conclusions about associations between HRV and disease severity within diseased populations.
  • Evident from the text: only 18 of 28 included studies provided suitable data for meta-analysis; most studies had moderate or serious bias, only 2 studies confirmed blinded HRV assessment, and NN50 was not presented in any study.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.14309/ctg.0000000000000275

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. IBD inflammatory bowel disease; IBS, irritable bowel syndrome; HRV, heart rate variability.
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. IBD inflammatory bowel disease; IBS, irritable bowel syndrome; HRV, heart rate variability.CC BY-NC-ND · PubMed Central
Figure 2. Forest plot for primary outcome comparing inflammatory bowel disease (IBD) with healthy controls (HC). CI, confidence interval; RMSSD, root mean square of successive RR interval differences.
Figure 2. Forest plot for primary outcome comparing inflammatory bowel disease (IBD) with healthy controls (HC). CI, confidence interval; RMSSD, root mean square of successive RR interval differences.CC BY-NC-ND · PubMed Central
Figure 3. Forest plots for all secondary outcomes available for meta-analysis comparing frequency domain heart rate variability (HRV) between inflammatory bowel disease (IBD) and healthy controls (HC). All studies were conducted over short recording lengths. Subanalyses were only possible for age and ulcerative colitis (UC) where indicated. High-frequency (HF), HF represented in normalized units (HFnu), low frequency (LF), LF represented in normalized units (LFnu), and very low frequency (VLF). CI, confidence interval.
Figure 3. Forest plots for all secondary outcomes available for meta-analysis comparing frequency domain heart rate variability (HRV) between inflammatory bowel disease (IBD) and healthy controls (HC). All studies were conducted over short recording lengths. Subanalyses were only possible for age and ulcerative colitis (UC) where indicated. High-frequency (HF), HF represented in normalized units (HFnu), low frequency (LF), LF represented in normalized units (LFnu), and very low frequency (VLF). CI, confidence interval.CC BY-NC-ND · PubMed Central
Figure 4. Forest plots for all secondary outcomes available for meta-analysis comparing high-frequency (HF) domain heart rate variability (HRV) between irritable bowel syndrome (IBS) and healthy controls (HC). Studies were separated by short and long duration recordings, with subanalyses for age, IBS subtype, and body mass index (BMI) where indicated. IBS with constipation predominant (IBS-C), HF represented in normalized units (HFnu), HF represented in the natural log (lnHF), low frequency (LF), LF represented in normalized units (LFnu). CI, confidence interval.
Figure 4. Forest plots for all secondary outcomes available for meta-analysis comparing high-frequency (HF) domain heart rate variability (HRV) between irritable bowel syndrome (IBS) and healthy controls (HC). Studies were separated by short and long duration recordings, with subanalyses for age, IBS subtype, and body mass index (BMI) where indicated. IBS with constipation predominant (IBS-C), HF represented in normalized units (HFnu), HF represented in the natural log (lnHF), low frequency (LF), LF represented in normalized units (LFnu). CI, confidence interval.CC BY-NC-ND · PubMed Central
Figure 5. Forest plots for all secondary outcomes available for meta-analysis comparing low-frequency (LF) domain heart rate variability (HRV) between irritable bowel syndrome (IBS) and healthy controls (HC). Studies were separated by short and long duration recordings, with subanalysis available for IBS with constipation predominant (IBS-C). LF represented in normalized units (LFnu). CI, confidence interval.
Figure 5. Forest plots for all secondary outcomes available for meta-analysis comparing low-frequency (LF) domain heart rate variability (HRV) between irritable bowel syndrome (IBS) and healthy controls (HC). Studies were separated by short and long duration recordings, with subanalysis available for IBS with constipation predominant (IBS-C). LF represented in normalized units (LFnu). CI, confidence interval.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

11 Valid · 3 Not valid · 7 Not checked · 52 Own results and interpretations

37 more claims · 2 with their cited sources checked

Create a free account to see all 73 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 21
  • It may state two separate claims as one. 14

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 75 references

Cited by

See all 45

Metadata

Authors
Sadowski, A., Dunlap, C., Lacombe, A., & Hanes, D.
Affiliations
National University of Natural Medicine (US)
Corresponding author
Sadowski, Adam
Venue
Clinical and Translational Gastroenterology
Published
2020-12-18
Volume
12
Issue
1
Pages
e00275
ISSN
2155-384X (ISSN-L)
OpenAlex
W3118231085
Cited by
45
References
75
Citations by year
2026: 10 · 2025: 12 · 2024: 5 · 2023: 14 · 2022: 3 · 2021: 1
FWCI
0.79
Type
journal article
Language
en
Open access
Locations
  • Clinical and Translational Gastroenterology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords
heart rate variability, irritable bowel syndrome, inflammatory bowel disease, autonomic nervous system, parasympathetic activity, gut-brain axis, high-frequency power, time-domain HRV, sympathetic nervous system
MeSH terms
Female, Heart Rate, Humans, Male, Parasympathetic Nervous System, Inflammatory Bowel Diseases, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.14309/ctg.0000000000000275
The paper
Sadowski, A., Dunlap, C., Lacombe, A., & Hanes, D. (2021). Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000275

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.